Tags

Type your tag names separated by a space and hit enter

The Challenges of Vaccine Development against a New Virus during a Pandemic.
Cell Host Microbe. 2020 05 13; 27(5):699-703.CH

Abstract

The rapid emergence of a highly pathogenic, readily transmissible coronavirus has resulted in a global pandemic, affecting millions and destabilizing economies. This catastrophe triggered a clarion call for the immediate deployment of a protective vaccine. We describe the unique challenges of developing a vaccine against SARS-CoV-2 in a pandemic setting.

Authors+Show Affiliations

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: diamond@wusm.wustl.edu.Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: piersontc@mail.nih.gov.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, U.S. Gov't, Non-P.H.S.

Language

eng

PubMed ID

32407708

Citation

Diamond, Michael S., and Theodore C. Pierson. "The Challenges of Vaccine Development Against a New Virus During a Pandemic." Cell Host & Microbe, vol. 27, no. 5, 2020, pp. 699-703.
Diamond MS, Pierson TC. The Challenges of Vaccine Development against a New Virus during a Pandemic. Cell Host Microbe. 2020;27(5):699-703.
Diamond, M. S., & Pierson, T. C. (2020). The Challenges of Vaccine Development against a New Virus during a Pandemic. Cell Host & Microbe, 27(5), 699-703. https://doi.org/10.1016/j.chom.2020.04.021
Diamond MS, Pierson TC. The Challenges of Vaccine Development Against a New Virus During a Pandemic. Cell Host Microbe. 2020 05 13;27(5):699-703. PubMed PMID: 32407708.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Challenges of Vaccine Development against a New Virus during a Pandemic. AU - Diamond,Michael S, AU - Pierson,Theodore C, PY - 2020/5/15/entrez PY - 2020/5/15/pubmed PY - 2020/5/19/medline SP - 699 EP - 703 JF - Cell host & microbe JO - Cell Host Microbe VL - 27 IS - 5 N2 - The rapid emergence of a highly pathogenic, readily transmissible coronavirus has resulted in a global pandemic, affecting millions and destabilizing economies. This catastrophe triggered a clarion call for the immediate deployment of a protective vaccine. We describe the unique challenges of developing a vaccine against SARS-CoV-2 in a pandemic setting. SN - 1934-6069 UR - https://www.unboundmedicine.com/medline/citation/32407708/The_Challenges_of_Vaccine_Development_against_a_New_Virus_during_a_Pandemic_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1931-3128(20)30248-1 DB - PRIME DP - Unbound Medicine ER -